Scinovex
articleTop 10% cited

Atropine for the Treatment of Childhood Myopia: Safety and Efficacy of 0.5%, 0.1%, and 0.01% Doses (Atropine for the Treatment of Myopia 2)

Ophthalmology · 2011 · Vol. 119(2) · pp. 347–354
Audrey ChiaWei‐Han ChuaYin‐Bun CheungWanling WongAnushia LinghamAllan FongDonald Tan

MeSH terms

Accommodation, OcularAdministration, TopicalAtropineChildDouble-Blind MethodFemaleHumansMaleMydriaticsMyopiaOphthalmic SolutionsPupilRefraction, OcularVisual AcuityTreatment Outcome
Citations
806
FWCI
9.38
field-weighted impact
References
35
Percentile
99%
vs. same field & year
Citations per year
Cited by
IMI Prevention of Myopia and Its Progression
Investigative Ophthalmology & Visual Science · 2021 · 408 citations
IMI – Interventions for Controlling Myopia Onset and Progression Report
Investigative Ophthalmology & Visual Science · 2019 · 431 citations
Retardation of Myopia in Orthokeratology (ROMIO) Study: A 2-Year Randomized Clinical Trial
Investigative Ophthalmology & Visual Science · 2012 · 784 citations
References
Incidence and Progression of Myopia in Singaporean School Children
Investigative Ophthalmology & Visual Science · 2004 · 394 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Atropine for the Treatment of Childhood Myopia: Safety and Efficacy of 0.5%, 0.1%, and 0.01% Doses (Atropine for the Treatment of Myopia 2) · Scinovex